nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—breast cancer	0.154	0.34	CiPCiCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—breast cancer	0.154	0.34	CiPCiCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—breast cancer	0.145	0.32	CiPCiCtD
Clofarabine—ABCG2—breast cancer	0.0902	1	CbGaD
Clofarabine—RRM2—Gemcitabine—breast cancer	0.0472	0.236	CbGbCtD
Clofarabine—RRM1—Gemcitabine—breast cancer	0.0472	0.236	CbGbCtD
Clofarabine—Cytarabine—Gemcitabine—breast cancer	0.0449	0.35	CrCrCtD
Clofarabine—Azacitidine—Gemcitabine—breast cancer	0.0427	0.333	CrCrCtD
Clofarabine—POLA1—Gemcitabine—breast cancer	0.0408	0.204	CbGbCtD
Clofarabine—Decitabine—Gemcitabine—breast cancer	0.0406	0.317	CrCrCtD
Clofarabine—DCK—Gemcitabine—breast cancer	0.0251	0.126	CbGbCtD
Clofarabine—ABCG2—Tamoxifen—breast cancer	0.00622	0.0311	CbGbCtD
Clofarabine—ABCG2—Mitoxantrone—breast cancer	0.00606	0.0303	CbGbCtD
Clofarabine—ABCG2—Paclitaxel—breast cancer	0.00484	0.0242	CbGbCtD
Clofarabine—ABCG2—Irinotecan—breast cancer	0.00477	0.0239	CbGbCtD
Clofarabine—ABCG2—Fluorouracil—breast cancer	0.00458	0.0229	CbGbCtD
Clofarabine—ABCG2—Carboplatin—breast cancer	0.00455	0.0228	CbGbCtD
Clofarabine—ABCG2—Docetaxel—breast cancer	0.0035	0.0175	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—breast cancer	0.00261	0.013	CbGbCtD
Clofarabine—ABCG2—Methotrexate—breast cancer	0.00253	0.0126	CbGbCtD
Clofarabine—POLA1—mammary gland—breast cancer	0.00101	0.0515	CbGeAlD
Clofarabine—RRM2—mammary gland—breast cancer	0.000962	0.0492	CbGeAlD
Clofarabine—RRM1—mammary gland—breast cancer	0.0008	0.0409	CbGeAlD
Clofarabine—RRM1—nipple—breast cancer	0.000661	0.0338	CbGeAlD
Clofarabine—RRM2—embryo—breast cancer	0.000657	0.0336	CbGeAlD
Clofarabine—DCK—nipple—breast cancer	0.000514	0.0263	CbGeAlD
Clofarabine—RRM2—skin of body—breast cancer	0.00051	0.0261	CbGeAlD
Clofarabine—POLA1—endometrium—breast cancer	0.000503	0.0257	CbGeAlD
Clofarabine—RRM2—endometrium—breast cancer	0.000481	0.0246	CbGeAlD
Clofarabine—POLA1—pituitary gland—breast cancer	0.000455	0.0233	CbGeAlD
Clofarabine—POLA1—adipose tissue—breast cancer	0.000453	0.0232	CbGeAlD
Clofarabine—RRM2—uterus—breast cancer	0.000443	0.0227	CbGeAlD
Clofarabine—RRM2—pituitary gland—breast cancer	0.000435	0.0222	CbGeAlD
Clofarabine—RRM2—adipose tissue—breast cancer	0.000433	0.0222	CbGeAlD
Clofarabine—DCK—embryo—breast cancer	0.000424	0.0217	CbGeAlD
Clofarabine—RRM1—skin of body—breast cancer	0.000424	0.0217	CbGeAlD
Clofarabine—POLA1—adrenal gland—breast cancer	0.000407	0.0208	CbGeAlD
Clofarabine—RRM1—endometrium—breast cancer	0.000399	0.0204	CbGeAlD
Clofarabine—RRM2—female reproductive system—breast cancer	0.000398	0.0204	CbGeAlD
Clofarabine—POLA1—bone marrow—breast cancer	0.000393	0.0201	CbGeAlD
Clofarabine—RRM2—adrenal gland—breast cancer	0.000389	0.0199	CbGeAlD
Clofarabine—POLA1—female gonad—breast cancer	0.000379	0.0194	CbGeAlD
Clofarabine—RRM2—bone marrow—breast cancer	0.000376	0.0192	CbGeAlD
Clofarabine—RRM1—uterus—breast cancer	0.000368	0.0188	CbGeAlD
Clofarabine—RRM2—female gonad—breast cancer	0.000362	0.0185	CbGeAlD
Clofarabine—RRM1—pituitary gland—breast cancer	0.000361	0.0185	CbGeAlD
Clofarabine—RRM1—adipose tissue—breast cancer	0.00036	0.0184	CbGeAlD
Clofarabine—RRM2—Gefitinib—Lapatinib—breast cancer	0.000347	0.268	CbGdCrCtD
Clofarabine—RRM2—endocrine gland—breast cancer	0.000337	0.0172	CbGeAlD
Clofarabine—RRM1—female reproductive system—breast cancer	0.000331	0.0169	CbGeAlD
Clofarabine—RRM1—adrenal gland—breast cancer	0.000323	0.0165	CbGeAlD
Clofarabine—RRM1—bone marrow—breast cancer	0.000312	0.016	CbGeAlD
Clofarabine—DCK—endometrium—breast cancer	0.00031	0.0159	CbGeAlD
Clofarabine—RRM1—female gonad—breast cancer	0.000301	0.0154	CbGeAlD
Clofarabine—Azacitidine—DNMT3A—breast cancer	0.000294	0.158	CrCbGaD
Clofarabine—Decitabine—DNMT3A—breast cancer	0.000287	0.154	CrCbGaD
Clofarabine—DCK—uterus—breast cancer	0.000286	0.0146	CbGeAlD
Clofarabine—DCK—pituitary gland—breast cancer	0.000281	0.0144	CbGeAlD
Clofarabine—RRM1—endocrine gland—breast cancer	0.00028	0.0143	CbGeAlD
Clofarabine—DCK—adipose tissue—breast cancer	0.00028	0.0143	CbGeAlD
Clofarabine—Azacitidine—CDA—breast cancer	0.000262	0.141	CrCbGaD
Clofarabine—DCK—female reproductive system—breast cancer	0.000257	0.0131	CbGeAlD
Clofarabine—DCK—adrenal gland—breast cancer	0.000251	0.0128	CbGeAlD
Clofarabine—POLA1—lymph node—breast cancer	0.000244	0.0125	CbGeAlD
Clofarabine—DCK—bone marrow—breast cancer	0.000243	0.0124	CbGeAlD
Clofarabine—DCK—female gonad—breast cancer	0.000234	0.012	CbGeAlD
Clofarabine—RRM2—lymph node—breast cancer	0.000233	0.0119	CbGeAlD
Clofarabine—DCK—endocrine gland—breast cancer	0.000217	0.0111	CbGeAlD
Clofarabine—RRM1—lymph node—breast cancer	0.000194	0.0099	CbGeAlD
Clofarabine—Adenosine monophosphate—PIM1—breast cancer	0.000178	0.0958	CrCbGaD
Clofarabine—ABCG2—endometrium—breast cancer	0.000173	0.00885	CbGeAlD
Clofarabine—ABCG2—uterus—breast cancer	0.000159	0.00816	CbGeAlD
Clofarabine—Azacitidine—DNMT1—breast cancer	0.000159	0.0854	CrCbGaD
Clofarabine—ABCG2—pituitary gland—breast cancer	0.000157	0.00801	CbGeAlD
Clofarabine—ABCG2—adipose tissue—breast cancer	0.000156	0.00798	CbGeAlD
Clofarabine—Decitabine—DNMT1—breast cancer	0.000155	0.0834	CrCbGaD
Clofarabine—Adenosine monophosphate—APRT—breast cancer	0.000152	0.0815	CrCbGaD
Clofarabine—DCK—lymph node—breast cancer	0.00015	0.00769	CbGeAlD
Clofarabine—Cytarabine—CDA—breast cancer	0.00015	0.0805	CrCbGaD
Clofarabine—DCK—Topotecan—Irinotecan—breast cancer	0.000143	0.11	CbGdCrCtD
Clofarabine—ABCG2—adrenal gland—breast cancer	0.00014	0.00715	CbGeAlD
Clofarabine—ABCG2—bone marrow—breast cancer	0.000135	0.00692	CbGeAlD
Clofarabine—POLA1—Vinblastine—Vinorelbine—breast cancer	0.000135	0.104	CbGdCrCtD
Clofarabine—ABCG2—female gonad—breast cancer	0.00013	0.00667	CbGeAlD
Clofarabine—RRM2—Vinorelbine—Vinblastine—breast cancer	0.000114	0.0876	CbGdCrCtD
Clofarabine—ABCG2—lymph node—breast cancer	8.39e-05	0.00429	CbGeAlD
Clofarabine—POLA1—Norethindrone—Fluoxymesterone—breast cancer	7.34e-05	0.0566	CbGdCrCtD
Clofarabine—DCK—Doxorubicin—Idarubicin—breast cancer	7.32e-05	0.0564	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Idarubicin—breast cancer	7.32e-05	0.0564	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Gemcitabine—breast cancer	7.29e-05	0.0562	CbGdCrCtD
Clofarabine—DCK—Clomifene—Toremifene—breast cancer	7.01e-05	0.054	CbGdCrCtD
Clofarabine—S-Adenosylmethionine—COMT—breast cancer	6.42e-05	0.0345	CrCbGaD
Clofarabine—Adenosine monophosphate—PDE4D—breast cancer	6.25e-05	0.0336	CrCbGaD
Clofarabine—Adenosine monophosphate—SRC—breast cancer	5.46e-05	0.0294	CrCbGaD
Clofarabine—RRM2—Azacitidine—Gemcitabine—breast cancer	4.58e-05	0.0353	CbGdCrCtD
Clofarabine—DCK—Clomifene—Tamoxifen—breast cancer	4.4e-05	0.0339	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Fluoxymesterone—breast cancer	4.12e-05	0.0318	CbGdCrCtD
Clofarabine—DCK—Doxorubicin—Epirubicin—breast cancer	3.36e-05	0.0259	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Doxorubicin—breast cancer	3.11e-05	0.024	CbGdCrCtD
Clofarabine—Cladribine—ABCG2—breast cancer	2.74e-05	0.0147	CrCbGaD
Clofarabine—Cytarabine—CYP3A4—breast cancer	1.49e-05	0.00798	CrCbGaD
Clofarabine—Anorexia—Docetaxel—breast cancer	1.12e-05	0.000164	CcSEcCtD
Clofarabine—Nervous system disorder—Capecitabine—breast cancer	1.11e-05	0.000163	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—breast cancer	1.11e-05	0.000163	CcSEcCtD
Clofarabine—Diarrhoea—Fluorouracil—breast cancer	1.11e-05	0.000163	CcSEcCtD
Clofarabine—Thrombocytopenia—Capecitabine—breast cancer	1.11e-05	0.000163	CcSEcCtD
Clofarabine—Tachycardia—Capecitabine—breast cancer	1.11e-05	0.000162	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—breast cancer	1.1e-05	0.000162	CcSEcCtD
Clofarabine—Skin disorder—Capecitabine—breast cancer	1.1e-05	0.000162	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—breast cancer	1.1e-05	0.000161	CcSEcCtD
Clofarabine—Hyperhidrosis—Capecitabine—breast cancer	1.1e-05	0.000161	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—breast cancer	1.09e-05	0.000161	CcSEcCtD
Clofarabine—Hypotension—Docetaxel—breast cancer	1.09e-05	0.000161	CcSEcCtD
Clofarabine—Haematuria—Doxorubicin—breast cancer	1.09e-05	0.00016	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—breast cancer	1.09e-05	0.00016	CcSEcCtD
Clofarabine—Abdominal pain—Paclitaxel—breast cancer	1.09e-05	0.00016	CcSEcCtD
Clofarabine—Body temperature increased—Paclitaxel—breast cancer	1.09e-05	0.00016	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—breast cancer	1.09e-05	0.00016	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—breast cancer	1.08e-05	0.000159	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—breast cancer	1.08e-05	0.000159	CcSEcCtD
Clofarabine—Anorexia—Capecitabine—breast cancer	1.08e-05	0.000159	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—breast cancer	1.08e-05	0.000158	CcSEcCtD
Clofarabine—Vomiting—Mitoxantrone—breast cancer	1.08e-05	0.000158	CcSEcCtD
Clofarabine—Vomiting—Irinotecan—breast cancer	1.08e-05	0.000158	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—breast cancer	1.07e-05	0.000158	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Dizziness—Fluorouracil—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Rash—Irinotecan—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Rash—Mitoxantrone—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Dermatitis—Irinotecan—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Dermatitis—Mitoxantrone—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—breast cancer	1.07e-05	0.000157	CcSEcCtD
Clofarabine—Chills—Methotrexate—breast cancer	1.07e-05	0.000156	CcSEcCtD
Clofarabine—Headache—Mitoxantrone—breast cancer	1.06e-05	0.000156	CcSEcCtD
Clofarabine—Headache—Irinotecan—breast cancer	1.06e-05	0.000156	CcSEcCtD
Clofarabine—Hypotension—Capecitabine—breast cancer	1.06e-05	0.000155	CcSEcCtD
Clofarabine—Paraesthesia—Docetaxel—breast cancer	1.05e-05	0.000154	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—breast cancer	1.05e-05	0.000154	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—breast cancer	1.05e-05	0.000154	CcSEcCtD
Clofarabine—Vomiting—Gemcitabine—breast cancer	1.05e-05	0.000154	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—breast cancer	1.04e-05	0.000153	CcSEcCtD
Clofarabine—Somnolence—Docetaxel—breast cancer	1.04e-05	0.000153	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—breast cancer	1.04e-05	0.000153	CcSEcCtD
Clofarabine—Rash—Gemcitabine—breast cancer	1.04e-05	0.000153	CcSEcCtD
Clofarabine—Dermatitis—Gemcitabine—breast cancer	1.04e-05	0.000152	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—breast cancer	1.03e-05	0.000152	CcSEcCtD
Clofarabine—Erythema—Methotrexate—breast cancer	1.03e-05	0.000152	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—breast cancer	1.03e-05	0.000152	CcSEcCtD
Clofarabine—Headache—Gemcitabine—breast cancer	1.03e-05	0.000152	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Capecitabine—breast cancer	1.03e-05	0.000152	CcSEcCtD
Clofarabine—Flushing—Epirubicin—breast cancer	1.03e-05	0.000151	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—breast cancer	1.03e-05	0.000151	CcSEcCtD
Clofarabine—Vomiting—Fluorouracil—breast cancer	1.03e-05	0.000151	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—breast cancer	1.03e-05	0.000151	CcSEcCtD
Clofarabine—Rash—Fluorouracil—breast cancer	1.02e-05	0.00015	CcSEcCtD
Clofarabine—Dermatitis—Fluorouracil—breast cancer	1.02e-05	0.00015	CcSEcCtD
Clofarabine—Paraesthesia—Capecitabine—breast cancer	1.02e-05	0.000149	CcSEcCtD
Clofarabine—Decreased appetite—Docetaxel—breast cancer	1.02e-05	0.000149	CcSEcCtD
Clofarabine—Hypersensitivity—Paclitaxel—breast cancer	1.02e-05	0.000149	CcSEcCtD
Clofarabine—Headache—Fluorouracil—breast cancer	1.02e-05	0.000149	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—breast cancer	1.02e-05	0.000149	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—breast cancer	1.01e-05	0.000149	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Docetaxel—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Dyspnoea—Capecitabine—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Nausea—Mitoxantrone—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Nausea—Irinotecan—breast cancer	1.01e-05	0.000148	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—breast cancer	1e-05	0.000147	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—breast cancer	1e-05	0.000147	CcSEcCtD
Clofarabine—Pain—Docetaxel—breast cancer	1e-05	0.000147	CcSEcCtD
Clofarabine—Back pain—Methotrexate—breast cancer	1e-05	0.000147	CcSEcCtD
Clofarabine—Chills—Epirubicin—breast cancer	9.97e-06	0.000146	CcSEcCtD
Clofarabine—Asthenia—Paclitaxel—breast cancer	9.91e-06	0.000145	CcSEcCtD
Clofarabine—Decreased appetite—Capecitabine—breast cancer	9.85e-06	0.000145	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—breast cancer	9.82e-06	0.000144	CcSEcCtD
Clofarabine—Nausea—Gemcitabine—breast cancer	9.79e-06	0.000144	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Capecitabine—breast cancer	9.78e-06	0.000144	CcSEcCtD
Clofarabine—Fatigue—Capecitabine—breast cancer	9.77e-06	0.000143	CcSEcCtD
Clofarabine—Pruritus—Paclitaxel—breast cancer	9.77e-06	0.000143	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—breast cancer	9.73e-06	0.000143	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—breast cancer	9.72e-06	0.000143	CcSEcCtD
Clofarabine—Pain—Capecitabine—breast cancer	9.69e-06	0.000142	CcSEcCtD
Clofarabine—Erythema—Epirubicin—breast cancer	9.67e-06	0.000142	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—breast cancer	9.67e-06	0.000142	CcSEcCtD
Clofarabine—Feeling abnormal—Docetaxel—breast cancer	9.64e-06	0.000142	CcSEcCtD
Clofarabine—Nausea—Fluorouracil—breast cancer	9.63e-06	0.000141	CcSEcCtD
Clofarabine—Gastrointestinal pain—Docetaxel—breast cancer	9.57e-06	0.00014	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—breast cancer	9.55e-06	0.00014	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—breast cancer	9.54e-06	0.00014	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—breast cancer	9.54e-06	0.00014	CcSEcCtD
Clofarabine—Diarrhoea—Paclitaxel—breast cancer	9.45e-06	0.000139	CcSEcCtD
Clofarabine—Back pain—Epirubicin—breast cancer	9.35e-06	0.000137	CcSEcCtD
Clofarabine—Feeling abnormal—Capecitabine—breast cancer	9.34e-06	0.000137	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—breast cancer	9.33e-06	0.000137	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—breast cancer	9.29e-06	0.000136	CcSEcCtD
Clofarabine—Gastrointestinal pain—Capecitabine—breast cancer	9.26e-06	0.000136	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—breast cancer	9.26e-06	0.000136	CcSEcCtD
Clofarabine—Abdominal pain—Docetaxel—breast cancer	9.25e-06	0.000136	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—breast cancer	9.25e-06	0.000136	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—breast cancer	9.25e-06	0.000136	CcSEcCtD
Clofarabine—Chills—Doxorubicin—breast cancer	9.22e-06	0.000135	CcSEcCtD
Clofarabine—Dizziness—Paclitaxel—breast cancer	9.13e-06	0.000134	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—breast cancer	9.08e-06	0.000133	CcSEcCtD
Clofarabine—Cough—Methotrexate—breast cancer	9.02e-06	0.000132	CcSEcCtD
Clofarabine—Mental disorder—Doxorubicin—breast cancer	9.01e-06	0.000132	CcSEcCtD
Clofarabine—Abdominal pain—Capecitabine—breast cancer	8.96e-06	0.000131	CcSEcCtD
Clofarabine—Body temperature increased—Capecitabine—breast cancer	8.96e-06	0.000131	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—breast cancer	8.95e-06	0.000131	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—breast cancer	8.95e-06	0.000131	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—breast cancer	8.94e-06	0.000131	CcSEcCtD
Clofarabine—Agitation—Epirubicin—breast cancer	8.89e-06	0.00013	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—breast cancer	8.8e-06	0.000129	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—breast cancer	8.8e-06	0.000129	CcSEcCtD
Clofarabine—Vomiting—Paclitaxel—breast cancer	8.78e-06	0.000129	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.74e-06	0.000128	CcSEcCtD
Clofarabine—Rash—Paclitaxel—breast cancer	8.71e-06	0.000128	CcSEcCtD
Clofarabine—Dermatitis—Paclitaxel—breast cancer	8.7e-06	0.000128	CcSEcCtD
Clofarabine—Leukopenia—Epirubicin—breast cancer	8.66e-06	0.000127	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—breast cancer	8.66e-06	0.000127	CcSEcCtD
Clofarabine—Headache—Paclitaxel—breast cancer	8.65e-06	0.000127	CcSEcCtD
Clofarabine—Hypersensitivity—Docetaxel—breast cancer	8.62e-06	0.000127	CcSEcCtD
Clofarabine—Cough—Epirubicin—breast cancer	8.44e-06	0.000124	CcSEcCtD
Clofarabine—Asthenia—Docetaxel—breast cancer	8.4e-06	0.000123	CcSEcCtD
Clofarabine—Infection—Methotrexate—breast cancer	8.38e-06	0.000123	CcSEcCtD
Clofarabine—DCK—Metabolism—MTR—breast cancer	8.38e-06	0.000219	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F1—breast cancer	8.37e-06	0.000219	CbGpPWpGaD
Clofarabine—Hypertension—Epirubicin—breast cancer	8.35e-06	0.000123	CcSEcCtD
Clofarabine—Hypersensitivity—Capecitabine—breast cancer	8.35e-06	0.000123	CcSEcCtD
Clofarabine—Pruritus—Docetaxel—breast cancer	8.28e-06	0.000122	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—breast cancer	8.27e-06	0.000121	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—breast cancer	8.27e-06	0.000121	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—breast cancer	8.26e-06	0.000121	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP1B1—breast cancer	8.25e-06	0.000216	CbGpPWpGaD
Clofarabine—Arthralgia—Epirubicin—breast cancer	8.23e-06	0.000121	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—breast cancer	8.23e-06	0.000121	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—breast cancer	8.22e-06	0.000121	CcSEcCtD
Clofarabine—DCK—Metabolism—HPGDS—breast cancer	8.21e-06	0.000215	CbGpPWpGaD
Clofarabine—Anxiety—Epirubicin—breast cancer	8.21e-06	0.00012	CcSEcCtD
Clofarabine—Nausea—Paclitaxel—breast cancer	8.2e-06	0.00012	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—breast cancer	8.19e-06	0.00012	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.18e-06	0.00012	CcSEcCtD
Clofarabine—DCK—Metabolism—HBA1—breast cancer	8.16e-06	0.000214	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	8.16e-06	0.000213	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Methotrexate—breast cancer	8.15e-06	0.00012	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	8.14e-06	0.000213	CbGpPWpGaD
Clofarabine—Asthenia—Capecitabine—breast cancer	8.13e-06	0.000119	CcSEcCtD
Clofarabine—RRM1—Metabolism—HSP90AA1—breast cancer	8.09e-06	0.000212	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP17A1—breast cancer	8.07e-06	0.000211	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK2—breast cancer	8.07e-06	0.000211	CbGpPWpGaD
Clofarabine—Anorexia—Methotrexate—breast cancer	8.04e-06	0.000118	CcSEcCtD
Clofarabine—Pruritus—Capecitabine—breast cancer	8.02e-06	0.000118	CcSEcCtD
Clofarabine—Leukopenia—Doxorubicin—breast cancer	8.01e-06	0.000118	CcSEcCtD
Clofarabine—Diarrhoea—Docetaxel—breast cancer	8.01e-06	0.000118	CcSEcCtD
Clofarabine—RRM2—Metabolism—PTGS1—breast cancer	7.99e-06	0.000209	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ENO1—breast cancer	7.99e-06	0.000209	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	7.98e-06	0.000209	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTT1—breast cancer	7.97e-06	0.000208	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ACHE—breast cancer	7.97e-06	0.000208	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CHST9—breast cancer	7.92e-06	0.000207	CbGpPWpGaD
Clofarabine—Oedema—Epirubicin—breast cancer	7.89e-06	0.000116	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—breast cancer	7.88e-06	0.000116	CcSEcCtD
Clofarabine—RRM1—Metabolism—NCOA1—breast cancer	7.87e-06	0.000206	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BIRC5—breast cancer	7.86e-06	0.000206	CbGpPWpGaD
Clofarabine—Infection—Epirubicin—breast cancer	7.84e-06	0.000115	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP2D6—breast cancer	7.83e-06	0.000205	CbGpPWpGaD
Clofarabine—Cough—Doxorubicin—breast cancer	7.81e-06	0.000115	CcSEcCtD
Clofarabine—RRM1—Metabolism—STK11—breast cancer	7.76e-06	0.000203	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP19A1—breast cancer	7.76e-06	0.000203	CbGpPWpGaD
Clofarabine—Diarrhoea—Capecitabine—breast cancer	7.75e-06	0.000114	CcSEcCtD
Clofarabine—Nervous system disorder—Epirubicin—breast cancer	7.74e-06	0.000114	CcSEcCtD
Clofarabine—Dizziness—Docetaxel—breast cancer	7.74e-06	0.000114	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—breast cancer	7.73e-06	0.000113	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—breast cancer	7.73e-06	0.000113	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—breast cancer	7.7e-06	0.000113	CcSEcCtD
Clofarabine—RRM2—Metabolism—NCOA2—breast cancer	7.69e-06	0.000201	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Methotrexate—breast cancer	7.68e-06	0.000113	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—breast cancer	7.67e-06	0.000113	CcSEcCtD
Clofarabine—Hyperhidrosis—Epirubicin—breast cancer	7.63e-06	0.000112	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK4—breast cancer	7.63e-06	0.0002	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—breast cancer	7.62e-06	0.000199	CbGpPWpGaD
Clofarabine—Arthralgia—Doxorubicin—breast cancer	7.62e-06	0.000112	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—breast cancer	7.62e-06	0.000112	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	7.6e-06	0.000199	CbGpPWpGaD
Clofarabine—Anxiety—Doxorubicin—breast cancer	7.59e-06	0.000111	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—breast cancer	7.57e-06	0.000111	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.57e-06	0.000111	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—breast cancer	7.55e-06	0.000197	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP17A1—breast cancer	7.54e-06	0.000197	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	7.54e-06	0.000197	CbGpPWpGaD
Clofarabine—Anorexia—Epirubicin—breast cancer	7.52e-06	0.00011	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—breast cancer	7.52e-06	0.00011	CcSEcCtD
Clofarabine—ABCG2—Metabolism—COX11—breast cancer	7.5e-06	0.000196	CbGpPWpGaD
Clofarabine—Somnolence—Methotrexate—breast cancer	7.5e-06	0.00011	CcSEcCtD
Clofarabine—Dizziness—Capecitabine—breast cancer	7.49e-06	0.00011	CcSEcCtD
Clofarabine—DCK—Metabolism—ENO1—breast cancer	7.46e-06	0.000195	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS1—breast cancer	7.46e-06	0.000195	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—FASN—breast cancer	7.46e-06	0.000195	CbGpPWpGaD
Clofarabine—Vomiting—Docetaxel—breast cancer	7.44e-06	0.000109	CcSEcCtD
Clofarabine—RRM2—Metabolism—BCHE—breast cancer	7.43e-06	0.000194	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—breast cancer	7.39e-06	0.000193	CbGpPWpGaD
Clofarabine—Rash—Docetaxel—breast cancer	7.38e-06	0.000108	CcSEcCtD
Clofarabine—Hypotension—Epirubicin—breast cancer	7.38e-06	0.000108	CcSEcCtD
Clofarabine—Dermatitis—Docetaxel—breast cancer	7.37e-06	0.000108	CcSEcCtD
Clofarabine—RRM2—Metabolism—SLC5A5—breast cancer	7.34e-06	0.000192	CbGpPWpGaD
Clofarabine—Decreased appetite—Methotrexate—breast cancer	7.33e-06	0.000108	CcSEcCtD
Clofarabine—Headache—Docetaxel—breast cancer	7.33e-06	0.000108	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP2D6—breast cancer	7.32e-06	0.000192	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.3e-06	0.000191	CbGpPWpGaD
Clofarabine—Oedema—Doxorubicin—breast cancer	7.3e-06	0.000107	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—breast cancer	7.28e-06	0.000107	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—breast cancer	7.27e-06	0.000107	CcSEcCtD
Clofarabine—Infection—Doxorubicin—breast cancer	7.26e-06	0.000107	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—breast cancer	7.24e-06	0.000189	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK2—breast cancer	7.22e-06	0.000189	CbGpPWpGaD
Clofarabine—Pain—Methotrexate—breast cancer	7.21e-06	0.000106	CcSEcCtD
Clofarabine—RRM1—Metabolism—COMT—breast cancer	7.21e-06	0.000189	CbGpPWpGaD
Clofarabine—Vomiting—Capecitabine—breast cancer	7.2e-06	0.000106	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—breast cancer	7.2e-06	0.000188	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Epirubicin—breast cancer	7.19e-06	0.000106	CcSEcCtD
Clofarabine—DCK—Metabolism—NCOA2—breast cancer	7.19e-06	0.000188	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTP1—breast cancer	7.18e-06	0.000188	CbGpPWpGaD
Clofarabine—Nervous system disorder—Doxorubicin—breast cancer	7.16e-06	0.000105	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—breast cancer	7.15e-06	0.000105	CcSEcCtD
Clofarabine—Rash—Capecitabine—breast cancer	7.14e-06	0.000105	CcSEcCtD
Clofarabine—Dermatitis—Capecitabine—breast cancer	7.14e-06	0.000105	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—breast cancer	7.13e-06	0.000105	CcSEcCtD
Clofarabine—Headache—Capecitabine—breast cancer	7.1e-06	0.000104	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—breast cancer	7.09e-06	0.000104	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—breast cancer	7.09e-06	0.000104	CcSEcCtD
Clofarabine—RRM2—Metabolism—NQO1—breast cancer	7.08e-06	0.000185	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC2A1—breast cancer	7.08e-06	0.000185	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HMOX1—breast cancer	7.08e-06	0.000185	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ITPR1—breast cancer	7.06e-06	0.000185	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—breast cancer	7.06e-06	0.000104	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—breast cancer	7.04e-06	0.000103	CcSEcCtD
Clofarabine—Somnolence—Epirubicin—breast cancer	7.02e-06	0.000103	CcSEcCtD
Clofarabine—DCK—Metabolism—FASN—breast cancer	6.97e-06	0.000182	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—breast cancer	6.97e-06	0.000182	CbGpPWpGaD
Clofarabine—Anorexia—Doxorubicin—breast cancer	6.96e-06	0.000102	CcSEcCtD
Clofarabine—Nausea—Docetaxel—breast cancer	6.95e-06	0.000102	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—breast cancer	6.95e-06	0.000102	CcSEcCtD
Clofarabine—DCK—Metabolism—BCHE—breast cancer	6.94e-06	0.000182	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	6.93e-06	0.000181	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP3A4—breast cancer	6.91e-06	0.000181	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Methotrexate—breast cancer	6.9e-06	0.000101	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CDA—breast cancer	6.86e-06	0.00018	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SHMT1—breast cancer	6.86e-06	0.00018	CbGpPWpGaD
Clofarabine—Decreased appetite—Epirubicin—breast cancer	6.86e-06	0.000101	CcSEcCtD
Clofarabine—DCK—Metabolism—SLC5A5—breast cancer	6.86e-06	0.000179	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—ATM—breast cancer	6.85e-06	0.000179	CbGpPWpGaD
Clofarabine—Hypotension—Doxorubicin—breast cancer	6.82e-06	0.0001	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDK4—breast cancer	6.82e-06	0.000178	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Epirubicin—breast cancer	6.81e-06	0.0001	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—breast cancer	6.81e-06	9.99e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP1B1—breast cancer	6.79e-06	0.000178	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCB1—breast cancer	6.79e-06	0.000178	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—breast cancer	6.75e-06	9.91e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN1B—breast cancer	6.75e-06	0.000177	CbGpPWpGaD
Clofarabine—Nausea—Capecitabine—breast cancer	6.73e-06	9.88e-05	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	6.7e-06	0.000175	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TYMS—breast cancer	6.67e-06	0.000175	CbGpPWpGaD
Clofarabine—Abdominal pain—Methotrexate—breast cancer	6.67e-06	9.79e-05	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—breast cancer	6.67e-06	9.79e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—HSP90AA1—breast cancer	6.66e-06	0.000174	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.65e-06	9.77e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—breast cancer	6.63e-06	0.000173	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NQO1—breast cancer	6.62e-06	0.000173	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC2A1—breast cancer	6.62e-06	0.000173	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLCO1B1—breast cancer	6.61e-06	0.000173	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A5—breast cancer	6.61e-06	0.000173	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—breast cancer	6.59e-06	0.000173	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NCOR1—breast cancer	6.59e-06	0.000173	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLA2G4A—breast cancer	6.59e-06	0.000173	CbGpPWpGaD
Clofarabine—Paraesthesia—Doxorubicin—breast cancer	6.56e-06	9.63e-05	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—breast cancer	6.51e-06	9.56e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—breast cancer	6.5e-06	9.55e-05	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—breast cancer	6.49e-06	9.53e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—NCOA1—breast cancer	6.48e-06	0.00017	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP3A4—breast cancer	6.46e-06	0.000169	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Epirubicin—breast cancer	6.45e-06	9.48e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—breast cancer	6.44e-06	0.000168	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—STK11—breast cancer	6.39e-06	0.000167	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP19A1—breast cancer	6.39e-06	0.000167	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APRT—breast cancer	6.38e-06	0.000167	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TFRC—breast cancer	6.38e-06	0.000167	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—breast cancer	6.35e-06	9.32e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP1B1—breast cancer	6.35e-06	0.000166	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GPX1—breast cancer	6.31e-06	0.000165	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Doxorubicin—breast cancer	6.31e-06	9.26e-05	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—breast cancer	6.3e-06	9.24e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP1A1—breast cancer	6.25e-06	0.000164	CbGpPWpGaD
Clofarabine—Pain—Doxorubicin—breast cancer	6.25e-06	9.17e-05	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—breast cancer	6.24e-06	9.16e-05	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—breast cancer	6.24e-06	9.16e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN1A—breast cancer	6.23e-06	0.000163	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HSP90AA1—breast cancer	6.22e-06	0.000163	CbGpPWpGaD
Clofarabine—Hypersensitivity—Methotrexate—breast cancer	6.21e-06	9.12e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—ERCC2—breast cancer	6.2e-06	0.000162	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NCOA2—breast cancer	6.14e-06	0.000161	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOA1—breast cancer	6.06e-06	0.000158	CbGpPWpGaD
Clofarabine—Asthenia—Methotrexate—breast cancer	6.05e-06	8.88e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Doxorubicin—breast cancer	6.02e-06	8.84e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ESRRA—breast cancer	6e-06	0.000157	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ANGPTL4—breast cancer	6e-06	0.000157	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Doxorubicin—breast cancer	5.97e-06	8.77e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—STK11—breast cancer	5.97e-06	0.000156	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP19A1—breast cancer	5.97e-06	0.000156	CbGpPWpGaD
Clofarabine—Pruritus—Methotrexate—breast cancer	5.97e-06	8.76e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—breast cancer	5.94e-06	0.000155	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—COMT—breast cancer	5.94e-06	0.000155	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RB1—breast cancer	5.93e-06	0.000155	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—breast cancer	5.91e-06	0.000155	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.86e-06	0.000153	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HMOX1—breast cancer	5.83e-06	0.000152	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—breast cancer	5.83e-06	0.000152	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—breast cancer	5.82e-06	8.54e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—ITPR1—breast cancer	5.81e-06	0.000152	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—breast cancer	5.78e-06	0.000151	CbGpPWpGaD
Clofarabine—Body temperature increased—Doxorubicin—breast cancer	5.77e-06	8.48e-05	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—breast cancer	5.77e-06	8.48e-05	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—breast cancer	5.77e-06	8.47e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GPI—breast cancer	5.69e-06	0.000149	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HADHB—breast cancer	5.69e-06	0.000149	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—breast cancer	5.66e-06	8.31e-05	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	5.66e-06	0.000148	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.66e-06	0.000148	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCB1—breast cancer	5.59e-06	0.000146	CbGpPWpGaD
Clofarabine—Pruritus—Epirubicin—breast cancer	5.58e-06	8.2e-05	CcSEcCtD
Clofarabine—Dizziness—Methotrexate—breast cancer	5.58e-06	8.19e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—COMT—breast cancer	5.55e-06	0.000145	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTP1—breast cancer	5.52e-06	0.000144	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TYMS—breast cancer	5.49e-06	0.000144	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HMOX1—breast cancer	5.45e-06	0.000142	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ITPR1—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NCOR1—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLA2G4A—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALDH7A1—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALDH1A1—breast cancer	5.43e-06	0.000142	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—breast cancer	5.4e-06	7.93e-05	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—breast cancer	5.38e-06	7.9e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—CAV1—breast cancer	5.38e-06	0.000141	CbGpPWpGaD
Clofarabine—Vomiting—Methotrexate—breast cancer	5.36e-06	7.87e-05	CcSEcCtD
Clofarabine—Rash—Methotrexate—breast cancer	5.32e-06	7.81e-05	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—breast cancer	5.31e-06	7.8e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MAPK3—breast cancer	5.31e-06	0.000139	CbGpPWpGaD
Clofarabine—Headache—Methotrexate—breast cancer	5.28e-06	7.76e-05	CcSEcCtD
Clofarabine—Asthenia—Doxorubicin—breast cancer	5.24e-06	7.69e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—ABCB1—breast cancer	5.23e-06	0.000137	CbGpPWpGaD
Clofarabine—Dizziness—Epirubicin—breast cancer	5.22e-06	7.66e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—UMPS—breast cancer	5.2e-06	0.000136	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FHL2—breast cancer	5.2e-06	0.000136	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PHGDH—breast cancer	5.2e-06	0.000136	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NME1—breast cancer	5.2e-06	0.000136	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ADSL—breast cancer	5.2e-06	0.000136	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GPX1—breast cancer	5.2e-06	0.000136	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NCOA1—breast cancer	5.17e-06	0.000135	CbGpPWpGaD
Clofarabine—Pruritus—Doxorubicin—breast cancer	5.17e-06	7.59e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MYC—breast cancer	5.16e-06	0.000135	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—breast cancer	5.16e-06	0.000135	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1A1—breast cancer	5.15e-06	0.000135	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TYMS—breast cancer	5.13e-06	0.000134	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ERCC2—breast cancer	5.11e-06	0.000134	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LDHB—breast cancer	5.1e-06	0.000133	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPSE—breast cancer	5.1e-06	0.000133	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BRIP1—breast cancer	5.1e-06	0.000133	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOR1—breast cancer	5.07e-06	0.000133	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—breast cancer	5.07e-06	0.000133	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLA2G4A—breast cancer	5.07e-06	0.000133	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—breast cancer	5.06e-06	0.000132	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PLG—breast cancer	5.04e-06	0.000132	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—breast cancer	5.02e-06	7.37e-05	CcSEcCtD
Clofarabine—Nausea—Methotrexate—breast cancer	5.01e-06	7.35e-05	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—breast cancer	5e-06	7.34e-05	CcSEcCtD
Clofarabine—Rash—Epirubicin—breast cancer	4.98e-06	7.31e-05	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—breast cancer	4.97e-06	7.3e-05	CcSEcCtD
Clofarabine—Headache—Epirubicin—breast cancer	4.94e-06	7.26e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—breast cancer	4.92e-06	0.000129	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—breast cancer	4.9e-06	0.000128	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GPX1—breast cancer	4.86e-06	0.000127	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCC1—breast cancer	4.84e-06	0.000127	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMMR—breast cancer	4.84e-06	0.000127	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA3—breast cancer	4.84e-06	0.000127	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—breast cancer	4.83e-06	7.09e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP1A1—breast cancer	4.81e-06	0.000126	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—breast cancer	4.8e-06	0.000126	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ERCC2—breast cancer	4.77e-06	0.000125	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—breast cancer	4.76e-06	0.000125	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—breast cancer	4.69e-06	6.88e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—PPARGC1B—breast cancer	4.68e-06	0.000123	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—HMOX1—breast cancer	4.65e-06	0.000122	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—breast cancer	4.64e-06	6.82e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN1B—breast cancer	4.62e-06	0.000121	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—breast cancer	4.6e-06	6.76e-05	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—breast cancer	4.6e-06	6.75e-05	CcSEcCtD
Clofarabine—Headache—Doxorubicin—breast cancer	4.58e-06	6.72e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—MTHFR—breast cancer	4.48e-06	0.000117	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—breast cancer	4.47e-06	0.000117	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAV1—breast cancer	4.43e-06	0.000116	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA9—breast cancer	4.42e-06	0.000116	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA4—breast cancer	4.42e-06	0.000116	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—breast cancer	4.4e-06	0.000115	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—breast cancer	4.34e-06	6.37e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GSTA2—breast cancer	4.31e-06	0.000113	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GPX2—breast cancer	4.31e-06	0.000113	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—breast cancer	4.3e-06	0.000113	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—breast cancer	4.26e-06	0.000111	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SULT1A1—breast cancer	4.26e-06	0.000111	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GPX4—breast cancer	4.26e-06	0.000111	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—breast cancer	4.25e-06	0.000111	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—breast cancer	4.24e-06	0.000111	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA1—breast cancer	4.16e-06	0.000109	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—IDH1—breast cancer	4.16e-06	0.000109	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAV1—breast cancer	4.14e-06	0.000108	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAT2—breast cancer	4.11e-06	0.000108	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NOS3—breast cancer	4.06e-06	0.000106	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—breast cancer	4.06e-06	0.000106	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—breast cancer	4.03e-06	0.000105	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—breast cancer	3.95e-06	0.000103	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—breast cancer	3.77e-06	9.86e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—breast cancer	3.75e-06	9.82e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—breast cancer	3.72e-06	9.73e-05	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK3—breast cancer	3.63e-06	9.5e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MED12—breast cancer	3.61e-06	9.43e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DPYD—breast cancer	3.61e-06	9.43e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALDOA—breast cancer	3.55e-06	9.29e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—breast cancer	3.54e-06	9.27e-05	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—breast cancer	3.53e-06	9.24e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—breast cancer	3.5e-06	9.15e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA3—breast cancer	3.45e-06	9.01e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A2—breast cancer	3.42e-06	8.95e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CPT1A—breast cancer	3.35e-06	8.77e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTR—breast cancer	3.35e-06	8.77e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NOS3—breast cancer	3.35e-06	8.76e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—breast cancer	3.31e-06	8.67e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPGDS—breast cancer	3.29e-06	8.6e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—breast cancer	3.27e-06	8.55e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HBA1—breast cancer	3.27e-06	8.55e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—breast cancer	3.24e-06	8.48e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ACHE—breast cancer	3.19e-06	8.34e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTT1—breast cancer	3.19e-06	8.34e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NOS3—breast cancer	3.13e-06	8.18e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—breast cancer	3.09e-06	8.08e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—breast cancer	3.06e-06	8.01e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP17A1—breast cancer	3.02e-06	7.9e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS1—breast cancer	2.99e-06	7.82e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ENO1—breast cancer	2.99e-06	7.82e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2D6—breast cancer	2.93e-06	7.66e-05	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—breast cancer	2.9e-06	7.59e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—breast cancer	2.89e-06	7.55e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA2—breast cancer	2.88e-06	7.52e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—breast cancer	2.86e-06	7.48e-05	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—breast cancer	2.79e-06	7.31e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FASN—breast cancer	2.79e-06	7.3e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BCHE—breast cancer	2.78e-06	7.27e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A5—breast cancer	2.74e-06	7.18e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—breast cancer	2.67e-06	6.98e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NQO1—breast cancer	2.65e-06	6.93e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A1—breast cancer	2.65e-06	6.93e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP3A4—breast cancer	2.58e-06	6.76e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1B1—breast cancer	2.54e-06	6.65e-05	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RAF1—breast cancer	2.53e-06	6.61e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—breast cancer	2.49e-06	6.53e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSP90AA1—breast cancer	2.49e-06	6.52e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA1—breast cancer	2.42e-06	6.34e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—STK11—breast cancer	2.39e-06	6.25e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP19A1—breast cancer	2.39e-06	6.25e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—breast cancer	2.29e-06	5.98e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—COMT—breast cancer	2.22e-06	5.81e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—breast cancer	2.21e-06	5.78e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMOX1—breast cancer	2.18e-06	5.7e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ITPR1—breast cancer	2.17e-06	5.69e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—breast cancer	2.09e-06	5.47e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—breast cancer	2.05e-06	5.37e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOR1—breast cancer	2.03e-06	5.31e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLA2G4A—breast cancer	2.03e-06	5.31e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—breast cancer	2.03e-06	5.31e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GPX1—breast cancer	1.94e-06	5.09e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—breast cancer	1.93e-06	5.04e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ERCC2—breast cancer	1.91e-06	5e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—breast cancer	1.88e-06	4.93e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—breast cancer	1.87e-06	4.89e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—breast cancer	1.79e-06	4.7e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—breast cancer	1.76e-06	4.6e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAV1—breast cancer	1.66e-06	4.33e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—breast cancer	1.54e-06	4.03e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—breast cancer	1.51e-06	3.94e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—breast cancer	1.44e-06	3.76e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—breast cancer	1.33e-06	3.47e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—breast cancer	1.31e-06	3.42e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NOS3—breast cancer	1.25e-06	3.27e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—breast cancer	1.16e-06	3.02e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—breast cancer	1.14e-06	3e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—breast cancer	9.98e-07	2.61e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—breast cancer	7.04e-07	1.84e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—breast cancer	5.75e-07	1.51e-05	CbGpPWpGaD
